VJHemOnc is committed to improving our service to you

ICML 2019 | Here’s looking at you: CLL research to watch

VJHemOnc is committed to improving our service to you

Barbara Eichhorst

Barbara Eichhorst, MD, University Hospital of Cologne, Cologne, Germany, discusses the chronic lymphocytic leukemia (CLL) studies to watch out for in the lead-up to and beyond the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition. Dr Eichhorst highlights the FLAIR trial of ibrutinib-containing regimens, including ibrutinib and venetoclax, in the frontline setting (ISRCTN01844152). This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter